Basel, 8 February 2016 – Straumann and botiss biomaterials are pleased to announce the opening of the 2016 Young Pro Award competition. Following the success of the inaugural event in 2015, the two sponsors have decided to run the competition again this year in order to synchronize the award with the main ‘bone and tissue days event’ in Berlin.

The award aims to foster and encourage the development of young dental professionals in the field of regenerative dentistry and dental biomaterials research.

Dental practitioners, students, researchers, etc., under the age of 35 may compete for the prize by submitting original work that contributes to the advancement of treatment/care or research in regenerative dentistry. Dissertations, projects or practical work experience may form the basis of the submission. The entries will again be adjudicated by a distinguished panel of experts in the field.

The 2016 award will be presented in Berlin, during the bone and tissue days conference, 9–10 September. It carries a cash prize of 10 000 euros and travel to the event. The successful submission will be subsequently published in Starget.

Complete details and the application process can be found at

http://www.straumann.com/youngproaward

About botiss biomaterials

Based in Berlin, Germany, botiss biomaterials is Europe’s second largest supplier of regenerative products and biomaterials. Its full range of clinically proven, high quality solutions includes membranes for guided tissue and bone regeneration, a full range of bovine, allogenic and synthetic bone graft materials, as well as soft-tissue-graft products. botiss biomaterials is a fast-growing entrepreneurial company, whose products are used in leading clinics around the world and are backed by many years of clinical experience. The company prides itself in innovations, such as its maxgraft^® bonering for simultaneous implant placement and bone augmentation, as well as the maxgraft^® bonebuilder, a bone block customized for individual patients.

About Straumann

Headquartered in Basel, Switzerland, Straumann (SIX: STMN) is a global leader in implant, restorative and regenerative dentistry. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and biomaterials for use in tooth replacement and restoration solutions or to prevent tooth loss. The Straumann Group currently employs approximately 3470 people worldwide. Its products and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners.